Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals

Neurology

Volumn 48, Issue 6, 1997, Pages 1598-1604

  Albers, Gregory W ^a,g   Bittar, N ^b   Young, L ^c   Hattemer, C R ^d   Gandhi, A J ^e   Kemp, S M ^a   Hall, E A ^f   Morton, D J ^f   Yim, J ^f   Vlasses, P H ^f  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b University of Wisconsin Health   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f University HealthSystem Consortium   (United States)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RISK FACTOR; STROKE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT CONTRAINDICATION; UNITED STATES; UNIVERSITY HOSPITAL;

EID: 17644445598     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.6.1598     Document Type: Article

References (34)

1. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
2. Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association. Guidelines for the management of transient ischemic attacks. Stroke 1994;25:1320-1335.
3. Matchar DB, McCrory DC, Barnett HJ, Feussner JR. Medical treatment for stroke prevention. Ann Intern Med 1994;121: 41-53.
4. Laupacis A, Albers G, Dalen J, Dunn M, Feinberg W, Jacobson A. Antithrombotic therapy in atrial fibrillation. Chest 1995;108:3528-3598.
5. Bath PM, Prasad A, Brown MM, MacGregor GA. Survey of use of anticoagulation in patients with atrial fibrillation. BMJ 1993;306:1045.
6. Lip GY, Tean KN, Dunn FG. Treatment of atrial fibrillation in a district general hospital. Br Heart J 1994;71:92-95.
7. O'Hare JA, Ul-Iman N, Geoghegan M. Non-anticoagulation in atrial fibrillation. Ir J Med Sci 1994;163:448-450.
8. Taylor F, Ramsay M. GPs not prepared for monitoring anticoagulation. BMJ 1993;307:1493.
9. Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol 1989;46:727-743.
10. Yasaka M, Yamaguchi T, Oita J, Sawada T, Shichiri M, Omae T. Clinical features of recurrent embolization in acute cardio-embolic stroke. Stroke 1993;24:1681-1685.
11. Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Stroke 1984;15:779-789.
12. Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: a randomized trial. Stroke 1983;14:668-676.
13. Furlan AJ, Cavalier SJ, Hobbes RE, Weinstein MA, Modie MT. Hemorrhage and anticoagulation after nonseptic embolic brain infarction. Neurology 1982;32:280-282.
14. Lodder J, Vanderlugt PJ. Evaluation of the risk of immediate anticoagulant treatment in patients with embolic stroke of cardiac origin. Stroke 1983;14:42-46.
15. Koller RL. Recurrent embolic cerebral infarction and anticoagulation. Neurology 1982;32:283-285.
16. Rothrock JF, Dittrich HC, McAllen S, Taft BJ, Lyden PD. Acute anticoagulation following cardioembolic stroke. Stroke 1989;20:730-734.
17. Sacco RL, Foulkes MA, Mohr JP, Wolf PA, Hier DB, Price TR. Determinants of early recurrence of cerebral infarction. The Stroke Data Bank. Stroke 1989;20:983-989.
18. Broderick JP, Phillips SJ, O'Fallon M, Wbisnant JP. Heart disease as a potential cause of stroke. Stroke 1990;21:173.
19. European Atrial Fibrillation Trial Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342:1255-1262.
20. Yamanouchi H, Nagura H, Mizutani T, Matsushita S, Esaki Y. Embolic brain infarction in nonrheumatic atrial fibrillation. A clinicopathologic study in the elderly. Neurology 1997 (in press).
21. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
22. Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996;330:540-546.
23. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348:633-638.
24. European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995; 333:5-10.
25. Hart RG, Easton DJ. Hemorrhagic infarcts. Stroke 1986;17: 586-589.
26. Sherman DG, Dyken ML, Gent M, Harrison M, Hart RG, Mohr JP. Antithrombotic therapy for cerebrovascular disorders: an update. Chest 1995;108:444S-456S.
27. Marsh EE, Adams HP, Biller J, Wasek P, Banwart K. Use of antithrombotic drugs in the treatment of acute ischemic stroke: A survey of neurologists in practice in the United States. Neurology 1989;39:1631-1634.
28. Pessin MS, Estol CJ, Lafranchise F, Caplan LR. Safety of anticoagulation after hemorrhagic infarction. Neurology 1993; 43:1298-1303.
29. Chaves DJ, Pessin MS, Caplan LR, et al. Cerebellar hemorrhagic infarction. Neurology 1996;46:346-349.
30. Albers GW. Atrial fibrillation and stroke; three new studies, three remaining questions. Arch Intern Med 1994;154:1443-1448.
31. Turpie AGG, Gent M, Laupacis A. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993;329:524-529.
32. DeRook FA, Comess KA, Albers GW, Popp RL. Transesophageal echocardiography in the evaluation of stroke. Ann Intern Med 1992;117:922-932.
33. Albers GW, Atwood JE, Hirsh J, Sherman DG, Hughes RA, Connolly SJ. Stroke prevention in nonvalvular atrial fibrillation. Ann Int Med 1991;115:727-736.
34. Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest 1995;108(suppl):335-351.